Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "— CNBC'S Michael Bloom"


25 mentions found


Citi is so bullish on one biotech firm that it has given its shares a target price that represents around 800% upside. In a Nov. 22 note, Citi gave the stock a buy rating and a price target of $90, representing potential upside of around 818% from Tuesday's price. However, the bank cautioned that the stock is high risk, given the "typical volatility" of biotech stocks and uncertainty associated with clinical trials. According to FactSet, analysts covering the stock give it average price target upside of 385% and a buy rating of 88%. On FactSet, the highest estimate came from Oppenheimer, which gives it potential upside of over 600%.
Persons: , Oppenheimer, — CNBC's Michael Bloom Organizations: Citi, Citi isn't, BMO Capital Markets, BMO, P Biotech ETF, Biotech Locations: U.S
The bank sees the S & P 500 ending 2024 at 4,200. "Equities are now richly valued with volatility near the historical low, while geopolitical and political risks remain elevated." Stocks have had a banner year in 2023, with the S & P 500 surging more than 18%. Those gains have been largely driven by sharp rallies from names tied to artificial intelligence, including Nvidia and Meta Platforms . Specifically, he sees S & P 500 profits growing 2% to 3% next year.
Persons: Bujas, Michael Bloom Organizations: JPMorgan, Nvidia, Meta, Federal Locations: U.S
Next year could be the year for certain dividend stocks, according to Wolfe Research. The S & P 500 Dividend Aristocrats Index is composed of companies that have increased dividends for at least 25 consecutive years. Here are some of the names in the S & P 500 Dividend Aristocrats Index. For investors who prefer funds, they can also get exposure through the ProShares S & P 500 Dividend Aristocrats exchange-traded fund. NOBL YTD mountain ProShares S & P 500 Dividend Aristocrats ETF — CNBC's Michael Bloom contributed reporting.
Persons: Chris Senyek, Senyek, Wolfe, Roz Brewer, Tim Wentworth, Wentworth, Medtronic, Michael Bloom Organizations: Wolfe Research, Federal, Materials, Walgreens, Shields Health,
For investors cheering stocks' strong rally into the year end, Barclays warned that it could be eating into 2024's return. A number of macro news events sparked a relief rally in equities as 2023 begins to wrap up, with the S & P 500 registering four straight weeks of gains and climbing 8.5% in November. "Combined with year-end seasonality, the surge in institutional flows could push equities over their skis, essentially 'borrowing' 2024 returns and leaving less room for upside next year," he added. .SPX YTD mountain S & P 500 The firm expects only single-digit returns next year as modest economic deceleration offsets the benefit of easing inflation. Barclays raised its 2024 S & P 500 price target to 4,800, from 4,500 previously.
Persons: Venu Krishna, Krishna, dovish, Treasury QRA, — CNBC's Michael Bloom Organizations: Barclays, Treasury, Big Tech, CNBC Pro's, Survey, Wall
The investment case for India is hard to argue with, according to analysts at Morgan Stanley — but they warn that upcoming elections with "potential binary outcomes sets the market up for volatility." "Government policy remains supportive, and the RBI (Reserve Bank of India) executes a calibrated exit from its current hold stance. For Morgan Stanley, the downside, or bear case, to its forecast would see India's elections result in a change in government. Focus list of overweight-rated stocks Looking ahead to India in 2024, Morgan Stanley is overweight on companies in the financials, consumer discretionary, industrials and technology sectors. From the financial services sector, Morgan Stanley is overweight on ICICI Bank and insurer SBI Life Insurance .
Persons: Morgan Stanley —, Ridham Desai, Narendra Modi, Morgan Stanley, — CNBC's Michael Bloom Organizations: Bombay Stock Exchange, Reserve Bank of India, International Monetary Fund, Maruti Suzuki, Hindustan Aeronautics, Infosys, ICICI Bank, SBI Life Insurance Locations: India, U.S, Government, F2026E
Rocket Lab shares have the potential to take off, according to Bank of America. Analyst Ronald Epstein reiterated his buy rating on the space stock while shaving his price target down by $2 to $10. Epstein's new price target implies the stock could soar 134.2% from Monday's close. After investigating the September mid-flight failure of its Electron rocket, Rocket Lab is aiming to get its launch business back on track by the end of the year. The analyst's price target cut followed a reassessment of the discount rate following the Electron launch snafu.
Persons: Ronald Epstein, Epstein, Bank of America's Epstein, Epstein doesn't, CNBC's Michael Bloom, Michael Sheetz Organizations: Bank of America, Bank of, MDA Locations: Monday's
A recent uptick for a broad-based tech ETF could signal that the market is ready for a rally in software stocks, regardless of size, according to Oppenheimer. Given Oppenheimer's coverage in the former, we think it's important to flag that the equal-weighted S & P Software & Services SPDR (XSW) reclaimed its Q2 breakout above its year-long bottoming pattern. A big rally for the XSW would be a change of pace from the strength of the so-called "Magnificent Seven" tech stocks that have dominated the market in 2023. And the fund's holdings mean that investors won't be adding even more exposure to all of the Magnificent Seven. Though the fund is broad, it does not include all categories of what many investors consider to be tech stocks.
Persons: Oppenheimer, Ari Wald, We're, — CNBC's Michael Bloom Organizations: P Software & Services, P Software, Services, Apple, Nvidia, Meta Locations: Technology
Lexeo Therapeutics ' stock could nearly double as its gene therapies advance through its pipeline, according to JPMorgan. That implies a potential upside of nearly 82% from the stock's Monday closing price of $11. LXEO ALL mountain Lexeo Therapeutics all-time stock chart Analyst Tessa Romero cited Lexeo Therapeutics' lead cardiac therapy, LX2006, as a catalyst for the stock. The gene therapy is delivered to body tissues through an adeno-associated virus vector and it targets a rare genetic heart disorder called Friedreich's ataxia cardiomyopathy. The firm is also evaluating a similar type of gene therapy, LX2020, to treat cases of PKP2-ACM, another kind of inherited heart disease.
Persons: Tessa Romero, Lexeo, Romero, LX2020, LX1001, – LX2006, Michael Bloom Organizations: Therapeutics, JPMorgan, Lexeo Therapeutics, ACM, ~$ Locations: U.S
Bernstein thinks the two best stocks to do so are Microsoft and Adobe. "Within our coverage, MSFT , and ADOBE are best positioned to profitably leverage GenAI, as they control a big portion of their AI tech stack," wrote analyst Mark Moerdler in a Tuesday note. Both Microsoft and Adobe have benefitted in 2023 from enthusiasm around AI and its growing addressable market in the wake of ChatGPT's debut. Earlier this year, Microsoft debuted its Copilot, which brings AI capabilities to its Office suite for $30 a month . "While the $30/month price tag generates handsome profit for Microsoft, it might be hardly profitable for others who have to rent model as a service," he wrote.
Persons: Bernstein, Mark Moerdler, They've, OpenAI, — CNBC's Michael Bloom Organizations: Microsoft, Adobe, ADOBE Locations: ChatGPT
Investors looking to cash in on the holiday trade may have missed the boat on Amazon , according to Bank of America. While Amazon tends to outperform retail stocks on Cyber Monday, history shows that the e-commerce giant typically lags the market between the popular online shopping day and Christmas, the bank's trading desk noted. Since 2016, Amazon's lagged the market during this period every single year, underperforming the SPDR S & P 500 ETF Trust (SPY) by the widest margin — 6% — in 2022, data shows. Year to date, the stock's rallied more than 75%. AMZN YTD mountain Amazon's year-to-date performance This Cyber Monday, Amazon outperformed the SPDR S & P Retail ETF by 1.3%.
Persons: Amazon's, — CNBC's Michael Bloom Organizations: Bank of America, Trust, Amazon, P
Analyst Julian Emanuel said investors should consider snapping up stocks that Evercore ISI calls "tax loss targets." Such stocks are being sold by investors looking to realize their losses and cut their 2023 tax bill before year-end. The average analyst has a buy rating and price target implying upside of about 32%, according to LSEG. The average analyst has a buy rating on the stock with a price target reflecting upside of nearly 39%, per LSEG. In addition to holding an average buy rating, analysts polled by LSEG forecast a price target implying Corteva could rally nearly 26% over the next year.
Persons: Julian Emanuel, Emanuel, there's, Aptiv, Piper Sandler, FactSet, Alexander Potter, LSEG, OkCupid, — CNBC's Michael Bloom Organizations: ISI, Pfizer, Aptiv, CNBC Pro, Wall, LSEG Locations: Israel
Analysts generally say that for consumers in China today, daily essentials, rather than discretionary goods, are in. Top picks Both are on Jefferies' top picks list for the China consumer in 2024. In addition to being a staple at business dinners in China, Moutai has tried to branch out with co-branding in chocolate, ice cream and coffee. But the company said it expected the Chinese market to "to return to mid single-digit growth" in coming periods. The firm analyzed 80 publicly-listed consumer companies with a majority of revenue from mainland China.
Persons: China haven't, Jefferies, they'd, Alibaba, Moutai, Gamble, It's, North America —, Andy, McKinsey's Daniel Zipser, — CNBC's Michael Bloom Organizations: OC, C, Nestle, PepsiCo, Procter, Foods, China, Pacific Sun Advisors, McKinsey Locations: China, Shanghai, Hong Kong, U.S, Wednesday's, Shenzhen, Friday's, China —, North America, Asia
Not every corner of the plant-based food industry has been burned. After the boom-and-bust cycle of Beyond Meat stock, analysts have wondered what comes next for the plant-based food space. The alternative protein market Beyond Meat's struggles have left some skeptical about which companies have what it takes to meet the needs of consumers who want to avoid animal-based products for health or environmental reasons. After topping $230 per share at its highest point, Beyond Meat stock now trades below $7. There's a business argument beyond the alternative protein market that can bode well when forecasting demand, Morningstar's Goldstein said.
Persons: Kristen Owen, Oppenheimer, Morgan Stanley, Michael Canfield, FactSet, Canfield, Corteva, Morningstar, Seth Goldstein, Goldstein, Vincent Andrews, Owen, Zepbound, milks, bode, Morningstar's Goldstein, Archer, Michael Bloom Organizations: Good Food Institute, Daniels, Midland Locations: Green Plains, U.S, Green, There's
Goldman names global growth stocks set to make a comeback
  + stars: | 2023-11-24 | by ( Weizhen Tan | ) www.cnbc.com   time to read: +1 min
European growth stocks haven't been doing as well as their U.S. peers this year. Growth stocks in the region have underperformed value stocks by 13% since the start of the rate-hiking cycle in 2022, according to Goldman Sachs in a Nov. 20 report. Bond yields appear to have peaked — a positive for growth stocks — and economic growth should speed up in the first quarter of next year — a positive for value stocks. The bank recommends an overweight rating for pure growth companies, namely those in its growth basket. Goldman said "pure growth" companies are more cyclical than quality stocks or stocks with stable margins.
Persons: Goldman Sachs, Goldman, Michael Bloom Organizations: Tech Locations: Europe
The use of weight-loss drugs such as Ozempic is poised to change consumer consumption patterns, but not every food-related company will get hit in the same way, according to Morgan Stanley. Fast food restaurants were especially vulnerable. "Shoppers with obesity spend more at large fast food brands and, on a relative basis, less at fast casual restaurants and casual diners," Morgan Stanley said. One stock that is closer to a risky pure play is McDonald's , which is second highest on the list, according to the Morgan Stanley research. Low cost retailers like Walmart and snack and beverage companies like Pepsico are also exposed, according to the Morgan Stanley research.
Persons: Morgan Stanley, Eli Lilly, Pamela Kaufman, Kaufman, Tim Hortons, Burger, Taco Bell, — CNBC's Michael Bloom Organizations: Novo Nordisk, Denmark's Novo Nordisk, Restaurant Brands, Yum Brands, Walmart, Pepsico Locations: U.S
One part of artificial intelligence will have an increasing role to play, according to Morgan Stanley. The theme, which it called "Edge AI," involves running AI algorithms directly on a user's device, be it a smartphone, laptop or wearable, among other things. Edge AI can help save costs, reduce latency (or lag time), among other benefits, Morgan Stanley said. MediaTek Morgan Stanley said MediaTek , the largest chip design house in Asia, is gearing up for Edge AI. Xiaomi Morgan Stanley said Xiaomi is a key beneficiary, given its first-mover advantage in Edge AI.
Persons: Morgan Stanley, Apple Morgan Stanley, Apple, DELL, Dell, MediaTek Morgan Stanley, MediaTek, Qualcomm Morgan Stanley, STMicroelectronics, Xiaomi Morgan Stanley, Xiaomi, — CNBC's Michael Bloom Organizations: Edge, Apple, Dell, PCS, Qualcomm, Hong Locations: Asia, Taiwan, Hong Kong
Asian stock markets may have had a weak year, but excessive cash in the region's companies is a hidden opportunity for investors, according to Jefferies. Asian ex-cash P/E is just 9.1 times, indicating "significant value," Jefferies' analysts noted. The region's stocks are also "appealing from the shareholder return perspective," given stronger prospects of buybacks backed by free cash flows and high cash balances, they wrote. Jefferies screened for Asian companies with "significant ex-cash value and strong fundamentals," and which it said make "good candidates" for buybacks and dividends. Other Asian stocks that made Jefferies' list include Singapore's transport company ComfortDelGro and Indian oil and gas company Petronet .
Persons: Jefferies, JD.com, iPhones, — CNBC's Michael Bloom Organizations: MSCI HK, Baidu, China Communications Services, Qingdao Port International, Energy, Vipshop Holdings, Technology, Singapore South, Kia, Hyundai, Orion Corp Locations: Asia, Pacific, Japan, China, Qingdao, South Korea, Australia, Singapore, Singapore South Korean
UBS has identified the stocks set to benefit from the growth of next-generation "solid-state" battery electric vehicles. Solid-state batteries are viewed as a potential breakthrough technology because they can store more energy than lithium-ion batteries and charge faster. Toyota's targets for solid-state batteries are about double the capacity of the longest-range Tesla vehicles. The automaker's planned transition to solid-state batteries for its EVs by the late 2020s makes the company's stock an attractive investment, according to the investment bank. The table below shows some of the global stocks best positioned to capitalize on the shift to solid-state batteries, according to UBS: UBS named Toyota Industries , which has already partnered with Toyota Motor on developing lithium-ion batteries, as another stock that could benefit from the shift to solid-state batteries.
Persons: Kohei Takahashi, Morgan Stanley, — CNBC's Michael Bloom Organizations: UBS, Toyota, Nissan, Honda, Toyota Industries, Toyota Motor, Mitsui Mining & Smelting, Sumitomo Metal Mining
Several analysts hiked their price targets for the stock to show they expect greater upside ahead after the latest financials. Below, CNBC Pro compiled a list of major investment firms that raised their price targets following the Nvidia report, along with their key conclusions: Goldman Sachs Analyst Toshiya Hari raised the price target by $20 to $625. Morgan Stanley Analyst Joseph Moore added $3 to his price target, bringing it to $603. BMO Capital Markets Like JPMorgan, BMO analyst Ambrish Srivastava hiked his target price by $50 to $650. Bernstein Analyst Stacy Rasgon increased his target price by $25 to $700, equating to 40% upside over the coming year.
Persons: Jensen Huang, chalked, Goldman Sachs, Toshiya Hari, Harlan Sur, Morgan Stanley, Joseph Moore, Aaron Rakers, Vivek Arya, Timothy Arcuri, NVDA, Ambrish Srivastava, Grace Hopper, Ruben Roy, Bernstein, Stacy Rasgon, Vijay Rakesh yanked, 2024E, INTC's, William Stein, Michael Bloom Organizations: Nvidia, CNBC Pro, Center, Foundry Service, JPMorgan, NVIDIA, " Bank of America, NVDA, UBS, BMO, Markets, AMD Locations: China, Tuesday's, CY24, CY25
The explosive growth of Temu, the U.S. arm of Chinese e-commerce giant Pinduoduo , could spell trouble for some major retailers, according to Bank of America. Just six months ago, Temu's sales were only 4% of Target's. The analysts say Temu's growth has been fueled by aggressive advertising using influencers, social media and search, with daily active users reaching 40% of Amazon's level. Retailers at risk The BofA analysts say retailers competing on price alone are particularly exposed to Temu's disruption. Separately, analysts at UBS investment bank also see Temu's growth in a similar vein.
Persons: Thomas Thornton, Kohl, Zara, Inditex, Pinduoduo, Lowe, CNBC's Michael Bloom Organizations: Bank of America, Consumers, of America's, Navy, Urban Outfitters, Walmart, Target, UBS, Costco Locations: Temu, U.S, United States, Swiss
Hedge funds' favorite stocks have crushed the broader market in 2023, returning 31%, thanks to mega-cap technology companies, according to Goldman Sachs. It then compiled a basket of the most popular long positions, dubbed Goldman's "Hedge Fund VIP basket," consisting of 50 stocks that most frequently appear among hedge funds' 10 largest holdings. "From an implementation standpoint, the Hedge Fund VIP list represents a tool for investors seeking to 'follow the smart money' based on 13-F filings," Goldman said. "Mirroring the increasing concentration in the equity market, concentration in hedge fund portfolios has risen; the typical hedge fund holds 70% of its long portfolio in its top 10 positions," Goldman said. Goldman also noted that the overweight in mega-cap names lifted hedge fund exposure to "momentum stocks" to a near record.
Persons: Goldman Sachs, Goldman, — CNBC's Michael Bloom Organizations: Microsoft, Devices
Investors should stick with quality stocks against a lackluster macroeconomic growth outlook, according to Goldman Sachs. "Despite our economists' optimistic US economic growth outlook, it seems likely that investor economic uncertainty will generally remain elevated next year," Kostin said. Here's a look at some of the quality stocks that made the Goldman list. SHW YTD mountain Sherwin-Williams stock. Kostin noted that growth stocks "typically outperform given stable economic growth and interest rates," while cyclicals "represent attractive tactical investments if economic data surprise to the upside relative to consensus expectations."
Persons: Goldman Sachs, Goldman, David Kostin, Kostin, Sam Altman, Altman, Sherwin, Williams, Michael Bloom Organizations: Federal, Microsoft, BMO Capital Locations: U.S
There's a new top dog when it comes to yields on 1-year certificates of deposit, according to an analysis by Stephens. Bread Financial now has the highest annual percentage yield for 1-year CDs among banks in Stephens' coverage at 5.6%. However, the online bank didn't reach the top by raising its APY. Instead, it was because LendingClub slashed its 1-year CD yield by 10 basis points to 5.55%, analyst Vincent Caintic said. "Online banks had already been cutting 1yr CD rates and this may likely continue as near-term rate expectations fall," Caintic said.
Persons: Stephens, LendingClub, Vincent Caintic, Caintic, What's, Austan Goolsbee, Jerome Powell, Michael Bloom, Jeff Cox Organizations: Bread, Federal Deposit Insurance Corporation, The Fed, Investors, Chicago Fed Locations: Stephens
The year-end rally we've been enjoying could get another lift as companies scoop up shares of their own stock. Those gains are driven mainly by falling Treasury yields, as well as third-quarter results that have come in largely better than anticipated. But some market observers expect equities could get another boost from the number of companies exiting the "buyback blackout" window. This period spans several weeks around quarterly results when companies are restricted from repurchasing shares. As of the survey's close last Tuesday, that would mean the S & P 500 would reach 4,945, or an all-time high.
Persons: we've, Strategas, Ryan Grabinski, Jill Carey, Grabinski, — CNBC's Michael Bloom Organizations: Bank, Investor
But even as the story continues unfolding, analysts already view Microsoft as well positioned coming out of the latest Silicon Valley spectacle. Ives, who reiterated his outperform rating and $425 price target for Microsoft, said the OpenAI board was "kids poker table and thought they won." "We view Microsoft now even in a STRONGER position from an AI perspective with Altman and Brockman at MSFT running AI," Ives wrote to clients Monday morning. Ives' price target is higher than the consensus on Wall Street of $403, according to LSEG, implying upside of slightly more than 9%. Materne has an outperform rating on the stock and a $432 price target.
Persons: Sam Altman, , Altman, MSFT, Dan Ives, Ives, Satya Nadella, Greg Brockman, Brockman, outperforming, Oppenheimer, Timothy Horan, Bing, Horan, ISI's Kirk Materne, Materne, Michael Bloom Organizations: Microsoft, Nasdaq Locations: OpenAI, Redmond, Wash
Total: 25